Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 09 Jun 2021 |
2 | Reply to Exam Report (MIS-R) | 09 Jul 2021 |
3 | Documents in support of Show cause Hearing (SCH) | 08 Jul 2022 |
4 | Authorization Letter | 14 Mar 2023 |
5 | Documents in support of Show cause Hearing (SCH) | 17 Mar 2023 |
6 | Authorization Letter | 26 May 2023 |
7 | Journal Copy | 27 Oct 2023 |
8 | Certificate | 30 Oct 2023 |
1 | EXAMINATION REPORT | 11653921 | 15 Jun 2021 | |
2 | Hearing Notice (Show Cause) | 13291274 | 04 Apr 2022 | |
3 | Hearing Notice (Show Cause) | 13606392 | 06 Jun 2022 | |
4 | Hearing Notice (Show Cause) | 14652095 | 17 Jan 2023 | |
5 | Hearing Notice (Show Cause) | 15166314 | 28 Apr 2023 | |
6 | Tribunal Accepted Notice for : 4999138 | 15333254 | 5979896 | 31 May 2023 |
Trademark was applied on 09 June 2021 with IP India.
Proprietor of Striparin is STRIDES PHARMA SCIENCE.
Class(es) in which the trademark was applied to is 5.
Status of Striparin is Registered.
Application number alloted to the trademark is 4999138.
Altacit Global is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD